Evidence map›Paper›PMID 36133698›Full record

ArticleNanoscale advances2022

Controlled release of carnosine from poly(lactic-

Kinana Habra, Robert H Morris, Stéphanie E B McArdle, Gareth W V Cave

Open access · goldAbstract read
In one paragraph

Article in Nanoscale advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Anticancer actions of carnosine in cellular models of prostate cancer.Journal of cellular and molecular medicine · 2024
    Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kinana HabraSchool of Science and Technology, Nottingham Trent University Nottingham NG11 8NS UK kinana.habra2017@ntu.ac.uk rob.morris@ntu.ac.uk gareth.cave@ntu.ac.uk +44(0)-115-848-3242.ORCID https://orcid.org/0000-0001-8272-6048
Robert H MorrisSchool of Science and Technology, Nottingham Trent University Nottingham NG11 8NS UK kinana.habra2017@ntu.ac.uk rob.morris@ntu.ac.uk gareth.cave@ntu.ac.uk +44(0)-115-848-3242.ORCID https://orcid.org/0000-0001-5511-3457
Stéphanie E B McArdleJohn van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University Nottingham NG11 8NS UK stephanie.mcardle@ntu.ac.uk.ORCID https://orcid.org/0000-0001-6929-9782
Gareth W V CaveSchool of Science and Technology, Nottingham Trent University Nottingham NG11 8NS UK kinana.habra2017@ntu.ac.uk rob.morris@ntu.ac.uk gareth.cave@ntu.ac.uk +44(0)-115-848-3242.ORCID https://orcid.org/0000-0002-4167-1332
Nottingham Trent University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanometer scale rods of superparamagnetic iron oxide have been encapsulated, along with the anti-cancer therapeutic carnosine, inside porous poly(lactic-

Identifiers

PMID36133698
PMCPMC9418447
OpenAlexW4293582571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.